Your browser doesn't support javascript.
loading
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
Cao, Yunlong; Yisimayi, Ayijiang; Jian, Fanchong; Song, Weiliang; Xiao, Tianhe; Wang, Lei; Du, Shuo; Wang, Jing; Li, Qianqian; Chen, Xiaosu; Yu, Yuanling; Wang, Peng; Zhang, Zhiying; Liu, Pulan; An, Ran; Hao, Xiaohua; Wang, Yao; Wang, Jing; Feng, Rui; Sun, Haiyan; Zhao, Lijuan; Zhang, Wen; Zhao, Dong; Zheng, Jiang; Yu, Lingling; Li, Can; Zhang, Na; Wang, Rui; Niu, Xiao; Yang, Sijie; Song, Xuetao; Chai, Yangyang; Hu, Ye; Shi, Yansong; Zheng, Linlin; Li, Zhiqiang; Gu, Qingqing; Shao, Fei; Huang, Weijin; Jin, Ronghua; Shen, Zhongyang; Wang, Youchun; Wang, Xiangxi; Xiao, Junyu; Xie, Xiaoliang Sunney.
Afiliação
  • Cao Y; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China. yunlongcao@pku.edu.cn.
  • Yisimayi A; Changping Laboratory, Beijing, P. R. China. yunlongcao@pku.edu.cn.
  • Jian F; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Song W; School of Life Sciences, Peking University, Beijing, P. R. China.
  • Xiao T; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Wang L; College of Chemistry and Molecular Engineering, Peking University, Beijing, P. R. China.
  • Du S; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Wang J; School of Life Sciences, Peking University, Beijing, P. R. China.
  • Li Q; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Chen X; Joint Graduate Program of Peking-Tsinghua-NIBS, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, P. R. China.
  • Yu Y; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, P. R. China.
  • Wang P; School of Life Sciences, Peking University, Beijing, P. R. China.
  • Zhang Z; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Liu P; School of Life Sciences, Peking University, Beijing, P. R. China.
  • An R; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, P. R. China.
  • Hao X; Institute for Immunology, College of Life Sciences, Nankai University, Tianjin, P. R. China.
  • Wang Y; Changping Laboratory, Beijing, P. R. China.
  • Wang J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, P. R. China.
  • Feng R; Changping Laboratory, Beijing, P. R. China.
  • Sun H; School of Life Sciences, Peking University, Beijing, P. R. China.
  • Zhao L; School of Life Sciences, Peking University, Beijing, P. R. China.
  • Zhang W; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Zhao D; Beijing Ditan Hospital, Capital Medical University, Beijing, P. R. China.
  • Zheng J; Changping Laboratory, Beijing, P. R. China.
  • Yu L; Changping Laboratory, Beijing, P. R. China.
  • Li C; CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, P. R. China.
  • Zhang N; Changping Laboratory, Beijing, P. R. China.
  • Wang R; Changping Laboratory, Beijing, P. R. China.
  • Niu X; Beijing Ditan Hospital, Capital Medical University, Beijing, P. R. China.
  • Yang S; Beijing Ditan Hospital, Capital Medical University, Beijing, P. R. China.
  • Song X; Changping Laboratory, Beijing, P. R. China.
  • Chai Y; Changping Laboratory, Beijing, P. R. China.
  • Hu Y; Changping Laboratory, Beijing, P. R. China.
  • Shi Y; Changping Laboratory, Beijing, P. R. China.
  • Zheng L; Changping Laboratory, Beijing, P. R. China.
  • Li Z; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Gu Q; College of Chemistry and Molecular Engineering, Peking University, Beijing, P. R. China.
  • Shao F; Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, P. R. China.
  • Huang W; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, P. R. China.
  • Jin R; Changping Laboratory, Beijing, P. R. China.
  • Shen Z; Institute for Immunology, College of Life Sciences, Nankai University, Tianjin, P. R. China.
  • Wang Y; Institute for Immunology, College of Life Sciences, Nankai University, Tianjin, P. R. China.
  • Wang X; Institute for Immunology, College of Life Sciences, Nankai University, Tianjin, P. R. China.
  • Xiao J; Changping Laboratory, Beijing, P. R. China.
  • Xie XS; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, P. R. China.
Nature ; 608(7923): 593-602, 2022 08.
Article em En | MEDLINE | ID: mdl-35714668
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Epitopos de Linfócito B / SARS-CoV-2 / COVID-19 / Deriva e Deslocamento Antigênicos / Tolerância Imunológica / Anticorpos Antivirais / Mutação Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Epitopos de Linfócito B / SARS-CoV-2 / COVID-19 / Deriva e Deslocamento Antigênicos / Tolerância Imunológica / Anticorpos Antivirais / Mutação Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article